Search - tctmd.com

Displaying 101 - 120 of 175

Sort: Relevancy | Date

News Daily News

REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients

Todd Neale

January 13, 2021

News Daily News

Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic

Michael O'Riordan

January 12, 2021

News Opinion CV Team Dispatch

January 2021 News Roundup

L.A. McKeown

January 01, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

Even Low-Dose Steroids Increase the Risk of CVD

Michael O'Riordan

December 03, 2020

News Daily News

More Women Than Men Develop HF or Die After STEMI

L.A. McKeown

December 01, 2020

News Conference News AHA 2020

One Pill to Treat Them All: Polycap Strategy Sees Success in TIPS-3

Michael O'Riordan

November 13, 2020

News Conference News

Blood Pressure Insights in COVID-19: Watch for Drops and RAAS Red Flags

L.A. McKeown

September 10, 2020

News Conference News ESC 2020

ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA

Michael O'Riordan

September 01, 2020

News Conference News ESC 2020

Antihypertensives Cut CV Events Across BP Levels, Regardless of Prior CVD: BPLTTC

Shelley Wood

August 31, 2020

News Daily News

US Mortality Rates for CVD Have Stalled as Racial Disparities Widen

Yael L. Maxwell

August 19, 2020

News Daily News

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

L.A. McKeown

August 12, 2020

News Daily News

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Michael O'Riordan

July 16, 2020

News Daily News

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

Yael L. Maxwell

May 21, 2020

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

News Features

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

Michael O'Riordan

April 24, 2020

News Daily News

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

Todd Neale

March 17, 2020

News Daily News

Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease

Michael O'Riordan

March 13, 2020

News Daily News

Hypertension Starts Years Earlier in Women Than Men, Serial BP Shows

L.A. McKeown

January 17, 2020

News Daily News

Nighttime Hypertension Drug Dosing May Reduce Risk of CVD

L.A. McKeown

October 23, 2019

Advertisement

REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients

Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic

January 2021 News Roundup

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Even Low-Dose Steroids Increase the Risk of CVD

More Women Than Men Develop HF or Die After STEMI

One Pill to Treat Them All: Polycap Strategy Sees Success in TIPS-3

Blood Pressure Insights in COVID-19: Watch for Drops and RAAS Red Flags

ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA

Antihypertensives Cut CV Events Across BP Levels, Regardless of Prior CVD: BPLTTC

US Mortality Rates for CVD Have Stalled as Racial Disparities Widen

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

Higher Risk of HF After ACS for Women Previously on Beta-blockers

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease

Hypertension Starts Years Earlier in Women Than Men, Serial BP Shows

Nighttime Hypertension Drug Dosing May Reduce Risk of CVD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content